
|Videos|August 9, 2022
Factors for Consideration when Choosing an ADT Regimen for mCSPC
Author(s)Jason Hafron, MD
Jason Hafron, MD, revisits the patient profile and discusses factors that inform treatment decision-making in mCSPC.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
Kari Tikkinen, MD, PhD, discusses POISE-3 findings on tranexamic acid in urologic surgery
5











